Cresset Asset Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.5K | Hold |
|
|||||
|
2025
Q1 | $27.1K | Sell |
|
|||||
|
2024
Q4 | $47.4K | Sell |
|
|||||
|
2024
Q3 | $114K | Sell |
|
|||||
|
2024
Q2 | $94.6K | Sell |
|
|||||
|
2024
Q1 | $296K | Buy |
|
|||||
|
2023
Q4 | $620K | Buy |
|
|||||
|
2023
Q3 | $477K | Buy |
|
|||||
|
2023
Q2 | $678K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $281K | Sell |
|
|||||
|
2022
Q2 | $214K | Buy |
|
|||||
|
2022
Q1 | $437K | Sell |
|
|||||
|
2021
Q4 | $1.04M | Sell |
|
|||||
|
2021
Q3 | $1.72M | Buy |
|
|||||
|
2021
Q2 | $2.34M | Buy |
|
|||||
|
2021
Q1 | $2.21M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $316K | Buy |
|